Unlocking Balance:
Designer Sponge RNAs
for Cellular Health Restoration

Ephyra is an RNA company developing a brand new class of therapeutic modality known as designer sponge RNAs. These target disease-causing molecules such as microRNAs to restore a healthy balance and treat disease.

About Us

National University of Singapore Spin-Out

Ephyra is a pre-seed staged company headquartered in Cambridge, UK.

Technology

Designer sponge RNAs represent a versatile toolbox with broad applicability across multiple therapeutic areas.

Platform

Our proprietary sponge RNA platform allows for the plug and play of different targets.

Partnerships

We are developing a pipeline of drugs for select indications and seeking strategic partners to work with.

Key Publications

Our Team

1

Lavenniah Annadoray

Co-Founder                            VP of R&D and Operations

Roger Foo

Co-Founder                              

SarahCole

Sarah Cole

Strategic Advisor

Dimitrios Zisoulis

Scientific Advisor

David Klinzing

Scientific Consultant

Board of Directors

Peter Simpson

Chairman         Director

Roger Foo

Non-Executive Director

Jason Mellad

Investor Director

Sarah Cole

Non-Executive Director

Investors and Partners

Contact Us

For all enquiries, please email us at info@ephyra.bio
We look forward to hearing from you.

Get Connected

Ephyra is a private limited company registered in England.
Company number: 13915017
Registered Office: Salisbury House, Station Road, Cambridge, CB1 2LA
VAT number GB: 415 7961 76

Copyright © 2023 Ephyra Ltd

Scroll to Top